R Lertkhachonsuk Selected Research

Platinum

1/2013

Salvage chemotherapy in recurrent platinum-resistant or refractory epithelial ovarian cancer with Carboplatin and distearoylphosphatidylcholine pegylated liposomal Doxorubicin (lipo-dox®).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R Lertkhachonsuk Research Topics

Disease

1	Ovarian Epithelial Carcinoma 01/2013
1	Fallopian Tube Neoplasms 01/2013
1	Atypical Squamous Cells of the Cervix 01/2006
1	Squamous Intraepithelial Lesions 01/2006
1	Uterine Cervical Dysplasia 01/2006
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2005
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2005
1	Carcinoma (Carcinomatosis) 05/2005

Drug/Important Bio-Agent (IBA)

1	Pharmaceutical PreparationsIBA 01/2013
1	1-dodecylpyridoxal (PLD)IBA 01/2013
1	1,2-distearoyllecithinIBA 01/2013
1	Carboplatin (JM8)FDA LinkGeneric 01/2013
1	PlatinumIBA 01/2013
1	liposomal doxorubicin (Doxil)FDA Link 01/2013
1	DNA (Deoxyribonucleic Acid)IBA 01/2006
1	Cisplatin (Platino)FDA LinkGeneric 05/2005
1	Gemcitabine FDA Link 05/2005

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2013 - 05/2005
1	Neoadjuvant Therapy 05/2005